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Effects of reduced renal mass on tissue lipids and renal injury in
hyperlipidemic rats. Increasing evidence from experimental models of
chronic renal failure suggests that abnormalities in lipid metabolism
may contribute to progressive renal injury. In the present study,
hyperlipidemic obese, and normolipemic lean Zucker rats were sub-
jected to unilateral nephrectomy or sham surgery at eight weeks of age.
After 32 weeks, renal injury was greater in obese than in lean rats, and
injury was made worse by nephrectomy. Among the major lipid classes,
increased renal cortical cholesteryl esters were positively correlated
with the degree of renal injury, suggesting that mechanisms analogous
to those thought to be important in the pathogenesis of atherosclerosis
may cause renal injury. Among phospholipid fatty acids, the ratio of
oleic to linoleic acids (18:1/18 2) was strongly linked to both glomerular
(r = 0.83, P < 0,01) and tubulo-interstitial (r = 0.80, P < 0.01) injury,
suggesting a possible role for a relative essential fatty acid deficiency in
renal injury. There were also strong, negative associations between
eicosapentaenoic acid levels and glomerular (r =
—0.63, P < 0.01) and
tubulointerstitial (r =
—0.71, P < .01) injury. Altogether, these results
suggest that specific abnormalities in renal lipid metabolism may be
important in the pathogenesis of chronic, progressive renal injury.
When immune or nonimmune-mediated injury causes a suf-
ficient reduction in the number of functioning nephrons, a
progressive deterioration in renal structure and function often
results. For this progression to occur, the original cause of
injury need not be present. A number of experiments, using
animal models of chronic renal failure, have attempted to define
mechanisms that may lead to progressive renal injury. In the rat
subtotal nephrectomy model, for example, increased glomeru-
lar pressures, altered renal prostaglandins, and coagulation
abnormalities have been shown to contribute to glomeruloscle-
rosis [1—5]. Abnormalities in lipid metabolism may also influ-
ence renal injury. Indeed, lipid lowering agents and diets
containing increased amounts of polyunsaturated fatty acids
have been shown to ameliorate injury in reduced renal mass
models of chronic renal failure [6—9].
Further evidence that abnormal lipid metabolism may be
important in the development and progression of renal injury
has come from studies of the obese Zucker rat model of type II
diabetes. Obesity in the Zucker rat is associated with abnor-
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malities in lipid metabolism that occur at a very early age [10].
Subsequently, obese Zucker rats develop spontaneous, pro-
gressive renal injury [11—13]. Lean littermates, on the other
hand, are normolipemic and maintain normal renal structure
and function [11—13]. In addition, antilipemic agents have been
shown to reduce serum lipids, and to decrease the amount of
glomerulosclerosis in obese Zucker rats [14].
Although a number of studies have indicated that lipid
abnormalities may influence the development and progression
of renal disease, how these abnormalities cause injury is un-
clear. Indeed, few measurements of renal lipids have been
reported in models of chronic renal failure. The injurious effect
of surgically reducing renal mass, for example, has been the
subject of numerous investigations, but the effects of this
maneuver on renal lipids are unknown. The present study was
designed to investigate whether specific alterations in renal
cortical lipids are associated with glomerular or interstitial
injury in the obese Zucker rat model of chronic renal injury.
Since reducing renal mass is known to accelerate injury in rats,
the effects of unilateral nephrectomy on renal lipids were also
investigated in both obese and lean rats. By using two-way
analysis of variance, the possible injurious effects of factors
associated with the obese genotype and nephrectomy were
studied independently. In addition, possible interactions be-
tween the effects of obesity-associated lipid alterations and
nephrectorny were examined. Finally, the relationship between
specific renal lipid alterations tnd renal injury was examined
using linear regression analysis.
Methods
Experimental design
The lean (FaJ?) and obese (fa/fa) Zucker rats used in these
experiments were obtained from a colony maintained at The
Hormel Institute, Austin, Minnesota, USA. Thirteen male,
obese Zucker rats were subjected to unilateral nephrectomy at
eight weeks of age. Sham surgery was performed in another 13
obese rats. In 12 lean littermates, unilateral nephrectomy was
carried out. Sham surgery was performed in eight lean Zucker
rats. All rats were fed standard rodent chow (Ralston Purina,
St. Louis, Missouri, USA) ad libitum. At 40 weeks of age, 32
weeks after surgery, the rats were subjected to ether anesthe-
sia, and renal tissue was removed surgically for histology and
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lipid analysis. Evaluation of renal histology was carried out in
each rat. Complete lipid analysis was performed on renal tissue
from 16 rats (4 rats from each of the 4 experimental groups).
Lipid extraction and analysis of major classes
Lipids were extracted from renal cortical tissue, and sepa-
rated by high performance liquid chromatography, using a
modification of techniques developed by Phillips and Privett,
and previously described in detail [15, 16]. Fresh renal cortical
tissue was heated in 0.05 N acetic acid (95°C) for 30 minutes to
destroy hydrolytic enzymes and organic-soluble, nonlipid con-
taminates. The suspension was then snap-frozen in liquid
nitrogen, and stored at —70°C until analyzed. When processed,
the thawed suspension was centrifuged at 12,500 rpm for 15
minutes. The supernatant was decanted, the pellet was resus-
pended in fresh 0.05 N acetic acid, and then centrifuged again.
This procedure was repeated two times. The centrifuged pellet
was next suspended in 20 ml of methanol (purified by distilla-
tion) and placed in a 50 ml centrifuge tube. Next, 20 ml of
chloroform (purified by distillation) was added and the mixture
was homogenized. The homogenate was allowed to stand for 15
minutes, and was then centrifuged at 3000 rpm for five minutes.
The pellet was again extracted with 40 ml of chloroform!
methanol (1:2), re-centrifuged, combined with the first super-
natant, and then evaporated to near dryness with a rotary
evaporator. The residue was resuspended in chloroform, fil-
tered through glass wool into screw-capped tubes, evaporated
to dryness with N2, and redissolved using 1 ml of chloroform
per g of tissue.
The tissue extracts were fractionated on a 0.2 X 45 cm silicic
acid column treated with ammonium hydroxide. This adsorbent
was prepared by stirring Spherisorb, S-GP, 8 (Phase Separa-
tion, Ltd., Hauppauge, New York, USA) with concentrated
ammonium hydroxide for 48 hours at room temperature.
Treated silicic acid was filtered and washed with methanol, air
dried for 12 hours and finally oven dried for one hour. The
column was slurry packed using a Haskel pump, Model DHF-
302A, at a pressure of 15,000 psi. The high performance liquid
chromatography was done using a Spectra Physics Model
3500B (Spectra Physics, Santa Clara, California, USA) pump-
ing system at 1000 psi to give a solvent flow rate of 0.6 mI/mm.
The eluent was passed through a flame-ionization detector
designed and constructed at the Hormel Institute. Fractionation
of extracts was begun by eluting cholesteryl ester, triacylglycer-
ols and other nonpolar components with methylene chloride.
This solvent was passed through the column for 10 minutes.
Next, chloroform/methylene chloride, 1: 1, vol/vol, was passed
through the column for 10 minutes to elute cholesterol. Then,
methanol containing 6% concentrated ammonium hydroxide
was added to this solvent in a 35-minute linear gradient. Tissue
lipids were expressed as percent of the total lipids.
Gas chromato graphic separation of fatty acids
The triacylglycerol and phospholipids were isolated from the
total lipid classes by thin layer chromatography using 20 X 20
cm glass plates with a 0.30 mm thick layer of silica gel H and a
development system of petroleum ether: dimethyl ether: acetic
acid (100:25: 1, vol/vol/vol). The triacylglycerol and phospho-
lipid zones were visualized using dichiorofluorescein spray
reagent and a UV lamp. The methyl esters of the fatty acids
were prepared by transesterification with 3 N methanol HC1.
The methyl esters were then analyzed on a Hewlett-Packard
Model 5840A gas chromatograph (Hewlett-Packard Co., Avon-
dale, Pennsylvania, USA) equipped with a flame ionization
detector and a fused silica capillary column (0.25 mm I.D. x 30
m) and a 0.25 micron film thickness of Durabond-225 (J & W
Scientific Inc., Rancho Cordova, California, USA). The tem-
perature was programmed from 160 to 225°C at two minutes
with a final temperature hold of 15 minutes at 225°C.
Histology
Coronal sections of the kidney were fixed in Zenker' s solu-
tion, paraffin imbedded, and stained with periodic acid-Schiff.
All tissue was examined in a blinded fashion. The incidence of
glomeruli with glomerulosclerosis was determined by examin-
ing all glomeruli in each tissue section using light microscopy
(400 x). Glomeruli with evidence of sclerosis had segmental or
global areas where capillary lumens had collapsed. These areas
were often, but not always, associated with adhesions to
Bowman's capsule.
The amount of tubulointerstitial damage was assessed by
examining 10, consecutively encountered, cortical fields using
light microscopy (bOx). Tubulointerstitial damage was char-
acterized by thickening of tubular basement membranes, tubu-
lar dilatation, intratubular cast formation, interstitial cell infil-
trates, and interstitial fibrosis. In each microscopic field, the
amount of tubulointerstitial damage was graded on a 0 to 4+
scale, where 0 corresponded to no damage, and 4+ represented
the most severe damage. The mean of the 10 determinations
was used as an index of tubulointerstitial damage for that piece
of tissue.
Statistics
All results are expressed as mean SD. Differences between
the four experimental groups were analyzed using two-way
analysis of variance (ANOVA). Univariate regression analysis
was carried out using the method of Pearson. All analysis was
performed using the Statistical Package for the Social Sciences
[17]. Differences were considered significant for P < 0.05.
Results
Body weight
Both the obese and lean rats grew well. Within genotypes,
nephrectomy did not affect growth (P > 0.5). At the end of the
experimental period, obese rats subjected to nephrectomy
weighed 523 43 g while sham-operated obese rats weighed
529 73. Lean nephrectomy rats weighed 323 39 g, and lean
sham-operated rats weighed 313 46 g.
Major lipid classes
Among the major lipid classes in the renal cortex, the most
remarkable difference between obese and lean Zucker rats was
in the triacylglycerol fraction (Table 1). Compared to lean rats,
obese Zucker rats had a two-fold increase in the percent of
lipids that were found in the triacylglycerol fraction. Nephrec-
tomy had little impact on triacylglycerols. However, nephrec-
tomy caused a significant increase in unesterified fatty acids and
monoacylglycerols (Table 1).
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Table 1. The effects of obesity and nephrectomy on major lipid classes in the kidneya
Obese Lean
SignificancebNx Control Nx Control
Lipid class (N = 4) (N = 4) (N = 4) (N = 4) Nx Obesity
Cholesteryl esters 2.0 0.5 1.1 0.2 1.1 0.1 1.3 0.4
Triacylglycerol 5.2 1.3 7.4 3.5 2.8 0.4 2.6 1,2 1'
Cholesterol 8.3 1.0 9.2 1.0 9.3 0.9 9.7 1.1
Diacylglycerol 1.5 0,3 1.9 0.3 1.6 0.1 1.8 0.3
Monoacylglycerol 1.1 0.1 0.5 0.2 0.9 0.1 0.8 0.1
Fatty acids 1.9 0.4 1.1 0.3 1.6 0.4 1.2 0.6 C
Diphosphatidylglycerol 3.6 1.7 3.0 0.3 2.8 0.6 3.3 0.5
Phosphatidylethanolamine 20.1 0.3 17.9 1.2 22.0 0.5 19.1 0.8 C
Phosphatidylinositol 3.0 0.3 4.6 0.7 2.9 0.6 4.4 0.7 C
Phosphatidylserine 4.8 1.1 4.2 0.8 4.6 0.5 4.3 0.5
Phosphatidylcholine 35.3 1.4 34.6 2.5 35.8 1.0 36.0 0.7
Sphingomyelin 13.5 1.5 14.5 1.3 14.8 2.1 15.8 1.2
a Values are means SD, expressed as percent of total lipid. Abbreviations: Nx, nephrectomy.b Arrows indicate statistically significant effects (two-way ANOVA, P < 0.05).
Among the phospholipids, nephrectomy was associated with
a decrease in phosphatidylinositol (Table 1). Obesity and ne-
phrectomy had opposing effects on phosphatidylethanolamine
(Table 1). There were no effects of either genotype or nephrec-
tomy on the remaining phospholipid classes.
The effects of the obese genotype and nephrectomy on levels
of cholesterol or cholesteryl esters did not reach statistical
significance (Table 1). However, there was a tendency for the
obese genotype and nephrectomy to be associated with a
relative decrease in unesterified cholesterol, while obese, ne-
phrectornized rats tended to have a relative increase in cho-
lesteryl esters (Table 1). Therefore, the ratio of esterified to
unesterified cholesterol (cholesteryl esters/cholesterol) was
0.25 0.09 in obese rats subjected to nephrectomy, and 0.12
0.03 in sham-operated obese rats. The ratio was 0.12 0,02 in
lean rats with and without nephrectomy. Because of the large
increase in the ratio of esterified to unesterified cholesterol in
the obese rats subjected to nephrectomy, the effects of obesity
and nephrectomy were both statistically significant by two-way
ANOVA (P < 0.05). In addition, there was a significant
interaction between these two effects (P < 0.05).
Phospholipid fatty acids
The phospholipid fatty acid profile of the obese rats was
substantially different when compared to that of their lean
littermates (Fig. 1, Table 2). In general, polyunsaturated fatty
acids were lower, and monounsaturated fatty acids were higher,
in the phospholipids of the obese rat kidneys compared to lean
littermates (Fig. 1). The proportion of saturated fatty acids was
similar in renal phospholipids from lean and obese rats (Fig. 1).
Among the individual phospholipid fatty acid classes, obesity
was associated with relative increases in palmitic (16:0), pal-
mitoleic (16:1), and oleic acids (18:1), while stearic (18:0),
linoleic (18:2), and eicosapentaenoic (20: 5w3) acids were de-
creased (Table 2).
Nephrectomy had no significant effect on the overall propor-
tion of phospholipids that were saturated, monounsaturated,
and polyunsaturated (Fig. 1). However, there was a tendency
for polyunsaturated phospholipid fatty acids to be lower in
obese rats subjected to nephrectomy (Fig. 1). Among individual
phospholipid fatty acids, nephrectomy was associated with a
reduction in arachidonic acid (20:4w6) that was evident only in
the obese rats (Table 2).
Triacy!glycero! fatty acids
Monounsaturated triacylglycerol fatty acids were relatively
increased in obese rats compared to their lean littermates (Fig.
2). The effects of the obese genotype on saturated and polyun-
saturated fatty acids were not statistically significant (Fig. 2).
The obese genotype was associated with a relative increase in
palmitoleic (16:1) and oleic (18:1) acids, with decreases in
stearic (18:0), arachidonic (20: 4w6), and eicosapentaenoic
(20:5w3) acids (Table 3).
Nephrectomy, on the other hand, was associated with overall
increases in saturated triacylglycerol fatty acids (Fig. 2). Poly-
unsaturated and monounsaturated triacylglycerol fatty acids
were decreased by nephrectomy (Fig. 2). Among individual
fatty acids in the triacylglycerol pool, palmitic acid (16:0) was
increased by nephrectomy, while oleic (18:1), linoleic (18:2),
arachidonic (20: 4w6), and eicosapentaenoic (20: 5w3) acids
were decreased (Table 3).
Lipid changes associated with renal injury
Glomeruloscierosis was more severe in the obese rats than in
the lean littermates. Nephrectomy significantly enhanced the
degree of glomerular injury. Thus, in obese, sham-operated
rats, 6.7 7.3% of the glomeruli were sclerotic, while the
incidence of glomeruloselerosis in lean, two kidney rats was 0.1
0.2%. In obese rats subjected to nephrectomy, 13.4 14.3%
of the glomeruli were sclerotic, while in the lean rats subjected
to nephrectomy 4.1 .2% had glomerulosclerosis. By two-way
ANOVA, the effects of nephrectomy and obesity were both
statistically significant (P < 0.01). There was no significant
interaction between the effects of nephrectomy and obesity on
glomerulosclerosis (P > 0.5).
The amount of tubulointerstitial injury closely paralleled the
degree of glomerular injury (r = 0.95 P < 0.01). Thus, the
tubulointerstitial injury score for obese, sham-operated rats was
1.4 0.8, while the amount of tubulointerstitial injury in lean,
two kidney rats was 0.2 0.2. The respective tubulointerstitial
scores for obese and lean rats that underwent nephrectomy
were 2.1 0.8 and 0.9 0.7. The effects of nephrectomy and
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Lean Obese
Fig. 1. The effects of obesity and nephrectomy on the degree of
saturation of phospholipid fatty acids. Note that the scales used for the
ordinate are varied in the different panels. Symbols are: (U) sham; (D)
nephrectomy.
obesity on tubulointerstitial injury were both statistically signif-
icant by two-way ANOVA (P < 0.01). There was no significant
interaction between the effects of nephrectomy and obesity on
tubulointerstitial injury (P > 0.5).
Among the major lipid classes, there was a trend for the
amount of glomerular injury to be positively associated with
cholesteryl esters, and negatively correlated with free choles-
terol (Table 4). However, in the case of glomerular injury, these
differences did not reach statistical significance. On the other
hand, there was a positive correlation between the ratio of free
to esterified cholesterol and glomeruloscierosis (Table 4). Sim.-
ilarly, there was a significant association between cortical
triacylglycerols and glomerular injury (Table 4). None of the
changes in the other major lipid classes were associated with
glomerular injury.
Overall, there was a negative association between total
polyunsaturated fatty acids, and a positive correlation between
total monounsaturated fatty acids and renal injury (Table 4).
There were also correlations between individual phospholipid
fatty acids and glomerulosclerosis. Positive correlations in-
cluded palmitic (16:0), palmitoleic (16:1), and oleic (18:1) acids
(Table 4). In contrast, linoleic (18:2) and eicosapentaenoic
(20: 5w3) acids correlated negatively with the degree of glomer-
ular injury (Table 4). The strongest correlation was found
between the ratio of oleic to linoleic acids (18: 1/18:2) and
glomeruloscierosis (Table 4).
The correlations between tubulointerstitial injury and renal
lipids were similar to those found for glomerulosclerosis (Table
4). Among the major lipid classes, there were positive correla-
tions between tubulointerstitial injury and cholesteryl esters,
the ratio of cholesteryl esters and free cholesterol, as well as
triacylglycerols (Table 4). Among phospholipid fatty acids,
there were strong positive correlations between tubulointersti-
tial injury and palmitic (16:0), palmitoleic (16:1), and oleic
(18: 1) acids (Table 4). There were strong negative correlations
between tubulointerstitial injury and linoleic (18:2) and eicosa-
pentaenoic (20: 5w3) acids (Table 4).
In general, correlations between triacylglycerol fatty acids
and renal injury were similar to those seen for fatty acids in the
phospholipid pool (data not shown). However, there was also a
significant negative correlation for triacylglycerol arachidonic
acid (20:4w6) with glomerulosclerosis (r = —0.50, P < 0.05) and
tubulointerstitial injury (r = —0.71, P < 0.01).
Discussion
In the present study, factors associated with the obese
genotype and nephrectomy both independently caused renal
injury in Zucker rats. In addition, obesity and nephrectomy
were each associated with alterations in renal lipids, and the
results suggested that these lipid alterations were closely linked
to the amount of renal injury. Although the results did not
indicate which, if any, of these lipid abnormalities were respon-
sible for the renal injury, they did suggest that several mecha-
nisms were potentially important. For example, the obese
genotype and nephrectomy both contributed to an increase in
the ratio of esterified to unesterified cholesterol, and there was
a significant association between cholesteryl esters and renal
injury. In addition, both the obese genotype and nephrectomy
were associated with alterations in fatty acids. Obesity was
associated with lower polyunsaturated, and higher monounsa-
turated, fatty acids in the phospholipids. Global alterations in
the degree of fatty acid saturation of membrane phospholipids
could have had detrimental effects on membrane fluidity and
function that contributed to renal injury. Moreover, obesity was
associated with a relative deficiency in essential fatty acids that
appeared to have been worsened by nephrectomy. This relative
essential fatty acid deficiency may have contributed to injury
through effects on renal eicosanoid production, or through
other mechanisms.
From the results of this study, the reason for the relative
increase in esterified cholesterol cannot be determined. How-
ever, increased free fatty acid levels were associated with
nephrectomy, and it is possible that increased availability of
free fatty acid substrate may have augmented the degree of
cholesterol esterification. In addition, alterations in fatty acid
saturation found in the present study (discussed below) may
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Table 2. The effects of obesity and nephrectomy on phosopholipid fatty acid composition in the kidneya
Obese Lean
SignificancebNx Control Nx Control
Fatty acid (N = 4) (N = 4) (N = 4) (N = 4) Nx Obesity
16:0 25.1 1.1 24.3 0.3 22.9 1.4 23.3 0.8 C
16:1 1.1 0.2 1.2 0.1 0.7 0.2 0.6 0.1 C
18:0 19,4 0.5 19.7 0.4 20.1 0.2 20.1 0.6
18:1w9 8.1 0.3 7.9 0.3 7.2 0.3 7.2 0.2 C
18:lw7 2.2 0.2 2.2 0.2 1.9 0.2 1.9 0.1 1'
18:2 9.0 1.2 8.1 0.6 10.5 1.2 10.1 0.4
20:3w6 0,5 0.1 0.6 0.1 0.4 0.1 0.6 0.1
20:4co6 20.6 1.2 23.6 0.8 21.7 0.5 21.6 0.8
20:5w3 0.7 0.2 0.7 0.2 1.2 0.1 1.0 0.2
22:0 0.9 0.1 0.7 0.1 0.9 0.1 0.8 0.1
22:5w3 0.5 0.1 0.4 0.1 0.4 0.1 0.4 0.1
22:6w3 2.3 0.2 2.6 0.1 2.7 0.1 2.7 0.4
24:0 5.0 0.6 5.1 0.3 5.8 0.4 5.8 0.3
24:1 1.5 0.1 1.4 0.1 1.6 0.2 1.6 0.1
a Values are means SD, expressed as percent of total phospholipid fatty acids. Abbreviation: Nx, nephrectomy.
b Arrows indicate statistically significant effects (two-way ANOVA, P < 0.05).
Table 3. The effects of obesity and nephrectomy on triacylglycerol fatty acid composition in the kidneya
Obese Lean
SignificancebNx Control Nx Control
Fatty acid (N = 4) (N = 4) (N 4) (N = 4) Nx Obesity
16:0 39.8 2.6 40.0 4.6 46.5 4.1 35.0 3.7 C
16:1 1.8 0.2 4.9 1.2 1.0 0.2 2.0 0.8 C
18:0 8.1 1.9 6.4 1.3 10.4 0.6 10.7 1.3 ,
18:1w9 18.4 4.7 22.9 3.5 12.3 3.1 17.4 2.8 C
l8:lio7 2.5 0.8 3.5 0.6 1.7 0.4 2.4 0.5 C
18:2 10.5 3.2 12.1 1.9 9.8 2.8 14,7 4.2
20:3w6 2.3 0.8 0.3 0.2 0.3 0.2 0.6 0.1
20:4w6 0.2 0.2 2.8 0.7 2.4 0.3 3.3 1.1
20:5w3 0.1 0.0 0.5 0.1 0.5 0,1 0,6 0.1
22:5o3 2.8 1.5 0.9 0.2 2.5 0.2 0.8 0.3 C
22:6ü3 1.4 0.6 4.0 0.9 0.6 0.5 2.7 1.1
a Values are means SD, expressed as percent of total triacylglycerol fatty acids. Abbreviation: Nx, nephrectomy.b Arrows indicate statistically significant effects (two-way ANOVA, P < 0.05).
have influenced the degree of cholesterol esterification. A
relative deficiency in essential fatty acids, for example, may
have inhibited cholesteryl ester hydrolase activity, and contrib-
uted to the relative increase in cholesteryl esters [18]. Other
mechanisms, associated with a relative deficiency of essential
fatty acids, may have also contributed to the accumulation of
cholesteryl esters [19].
It is possible that the relative accumulation of cholesteryl
esters may have contributed to the development and progres-
sion of renal injury in the present study, and may have caused
injury by mechanisms analogous to those felt to be important in
the pathogenesis of atherosclerosis. Although the mechanism
whereby cholesteryl esters may contribute to vascular injury is
unknown, cholesteryl ester accumulation occurs very early in
the development of atherosclerotic plaques [20—22]. Alterations
resulting from cholesteryl ester deposition may, directly or
indirectly, lead to the recruitment of tissue macrophages [23,
24]. Cholesteryl esters accumulate in tissue macrophages and
are thought to be important in the formation of foam cells
commonly seen in early atherosclerotic lesions [25, 26]. These
foam cells, in turn, may release inflammatory mediators that
ultimately result in cell injury. A similar sequence of events
could explain the association between cholesteryl esters and
renal injury noted in the present study.
It has been shown that glomerular injury in obese Zucker rats
is associated with an increased number of cells in the mesan-
gium [14]. Although, the origin of these glomerular cells re-
mains speculative, it is possible that they represent macro-
phages, and lead to the formation of glomerular foam cells
observed in this model (unpublished observations). Thus, alter-
ations in cholesterol metabolism may have influenced renal
injury through effects on macrophages. However, other mech-
anisms may also explain the association between cholesteryl
ester accumulation and renal injury seen in the present study.
The results of this investigation also demonstrated that obese
Zucker rats had a relative decrease in total phospholipid poly-
unsaturated fatty acids compared to their lean littermates.
Moreover, the relative changes in the degree of fatty acid
saturation correlated with the amount of renal injury. A de-
crease in the relative proportion of unsaturated phospholipid
fatty acids is known to have deleterious effects on cell function
[27]. Decreased phospholipid fatty acid saturation causes alter-
ations in membrane fluidity [27]. Altered membrane fluidity, in
turn, interferes with the normal function of membrane-bound
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Fig. 2. The effects of obesity and nephrectomy on the degree of
saturation of the triacyglycerol fatty acids. Note that the scales used for
the ordinate are varied in the different panels. Symbols are: (El) sham;
() nephrectomy.
enzymes important in the maintenance of cellular homeostasis
[28]. Thus, alterations in the relative degree of phospholipid
fatty acid saturation, and the resulting membrane dysfunction,
could have contributed to the renal injury seen in the obese
Zucker rats.
There was also a strong correlation between the amount of
renal injury and the ratio of oleic to linoleic fatty acids. This
correlation suggests that a relative deficiency of essential fatty
acids in the obese Zucker rats may have contributed to renal
injury (Fig. 3). Compared to lean littermates, obese Zucker rats
have been shown to have increased levels of saturated fatty
acids in liver and adipose tissue [29, 301. In addition, the
monodesaturation of stearate and palmitate was greater in
obese Zucker rats than in lean littermates [291. The fatty acid
distribution seen in the present study was similar to that
Tubulointerstitial
Glomeruloscierosis damage
Major lipid classes
Cholesterol —0.38 —0.43
Cholesteryl esters 0.36 0.51
Cholesteryl esters/chol. 0.5 l 0.56a
Triacylglycerides o.56a 066b
Total phospholipid fatty
acids
Polyunsaturates
Monounsaturates 0•79b 082b
Saturates 0.17 0.10
Phospholipid fatty acids
16:0 0.59a 0.57a
16:1 076b 070b
18:0 —0.48 —0.58
18:lio9 079b 088b
18:2 067b
18: 1/18:2 083b 080b
20:3w6 0.18 0.02
20:4w6 0.23 0.06
20:5co3
previously reported for liver and adipose tissue fatty acids in
obese Zucker rats, and resembles that observed in tissues from
animals with early essential fatty acid deficiency [31]. Indeed,
the increased ratio of oleic to linoleic acids represents a relative
deficiency of essential fatty acids, because these two fatty acid
substrates compete for the same -6 desaturase enzyme.
The present study also suggests that nephrectomy may have
caused an increased demand for essential fatty acids that,
combined with the relative essential fatty acid deficiency asso-
ciated with the obese genotype, contributed to the renal injury.
Soon after nephrectomy, renal prostaglandin production in-
creases [32]. An increased production of renal prostaglandins
may have placed a greater demand on renal essential fatty acids
in the nephrectomized, obese Zucker rats. Indeed, phospho-
lipid arachidonic acid, the substrate for the cyclooxygenase
enzyme, was decreased by nephrectomy in the obese Zucker
rats. Although there was no correlation between phospholipid
arachidonic acid levels and renal injury (Table 5), there was a
significant negative association between triacylglycerol arachi-
donic acid levels and injury. This could indicate that the
increased demand for phospholipid arachidonic acid associated
with injury was met at the expense of arachidonic acid levels in
the triacylglycerol pool. Whether changes in arachidonic acid
metabolism directly or indirectly influenced renal injury cannot
be determined from these results.
Several other studies have suggested that essential fatty acids
may be important mediators of renal injury. Feeding rats an
essential fatty acid deficient diet has been shown to cause renal
damage [31]. It has also been shown that diets rich in linoleic
acid reduced the amount of injury in rat models of chronic renal
failure [7, 9]. The mechanism whereby long chain, polyunsatu-
rated fatty acids influenced renal injury in these models is
unknown. However, polyunsaturated fatty acids are precursors
for prostaglandins and leukotrienes. These locally active hor-
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Table 4. Association (r-values) between renal injury and cortical
lipids
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Fig. 3. Associations between cholesteryl esters, triacylglycerols, and
phosphol ipid fatty acids and renal injury. Arrows indicate statistically
significant correlations between the lipid class and renal injury (P <
0.05). Arrows pointing down correspond to negative correlations, and
vice versa. The broken arrow indicates that the significant negative
correlation was between renal injury and arachidonic acid in the
triacyiglycerols only.
mones affect vascular resistance, platelet aggregability, and
help to mediate the inflammatory response. All of these effects
may be important in the pathogenesis of renal injury. Thus, it is
possible that alterations in polyunsaturated fatty acid eicosa-
noid precursors may be important in the development of renal
injury in the Zucker rats.
In the present investigation there was a negative association
between eicosapentaenoic acid and renal injury. Recent studies
have shown possible beneficial effects of diets supplemented
with eicosapentaenoic acid in obese Zucker rats and in other
animal models of chronic renal disease [8, 33, 34]. The mecha-
nism whereby w-3 fatty acids appear to ameliorate renal injury
in these investigations is unknown, but speculation has focused
on possible favorable alterations in eicosanoid metabolism [8].
It is thought that w-3 fatty acid precursors may favorably affect
the balance between prostanoids that vasodilate and inhibit
platelet aggregation on the one hand, with those that vasocon-
strict and enhance platelet aggregation on the other [351. Thus,
it is possible that the negative association between eicosapen-
taenoic acid and renal injury seen in the present study resulted
from deleterious effects of reduced levels of this fatty acid on
renal eicosanoid production.
Although the results of this study demonstrated an associa-
tion between cortical lipids and progressive renal injury, further
investigations will be required to determine more precisely
where, within the kidney cortex, the renal lipid alterations
occurred. Since the proportion of the cortex made up of
glomeruli is relatively small, alterations in total cortical lipids
may not reflect changes in glomerular lipids. It is possible that
the lipid alterations found in the present investigation were\ confined to renal tubular cells. Thus, additional investigations
will be required to determine whether associations between
abnormal lipid metabolism and injury occur in both glomeruli
and tubules. Similarly, changes in phospholipids, and phospho-
lipid fatty acids, largely reflect alterations in membrane lipids.
However, the relative contribution from plasma, mitochondrial,
lysosomal, or other membrane fractions to alterations in the
phospholipids were not determined. Further studies to charac-
terize lipid alterations in isolated membrane fractions may
suggest specific mechanisms whereby lipid alterations lead to
cell injury.
In summary, this investigation demonstrated that specific
abnormalities in renal lipids may be important in the pathogen-
esis of progressive renal injury. Alterations in cholesterol
esterification and fatty acid metabolism correlated closely with
the renal injury caused by nephrectomy and obesity in the
Zucker rat -model of chronic renal failure. The possible impor-
tance of renal lipid abnormalities in human renal disease re-
mains to be determined. However, plasma lipid abnormalities
are almost invariably present in patients who ultimately prog-
ress to end-stage renal disease. Thus, it is important to examine
the impact of these lipid abnormalities on the kidney, and to
clarify the mechanisms whereby abnormal lipid metabolism
may influence the development and progression of renal injury.
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